Drug Search Results
More Filters [+]


Alternative Names: felypressin
Latest Update: 2024-01-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: V1 Agonist,V2 Agonist,V3 Agonist

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Brazil | Germany | Malta | New Zealand | Norway | Portugal | South Africa | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Taibah University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Felypressin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events